Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- PMID: 23103127
- PMCID: PMC3594632
- DOI: 10.1016/j.it.2012.10.001
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Abstract
Sustained access to nutrients is a fundamental biological need, especially for proliferating cells, and controlling nutrient supply is an ancient strategy to regulate cellular responses to stimuli. By catabolizing the essential amino acid TRP, cells expressing the enzyme indoleamine 2,3 dioxygenase (IDO) can mediate potent local effects on innate and adaptive immune responses to inflammatory insults. Here, we discuss recent progress in elucidating how IDO activity promotes local metabolic changes that impact cellular and systemic responses to inflammatory and immunological signals. These recent developments identify potential new targets for therapy in a range of clinical settings, including cancer, chronic infections, autoimmune and allergic syndromes, and transplantation.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Immunol Invest. 2012;41(6-7):738-64. doi: 10.3109/08820139.2012.676122. Immunol Invest. 2012. PMID: 23017144 Free PMC article. Review.
-
Control of immune response by amino acid metabolism.Immunol Rev. 2010 Jul;236:243-64. doi: 10.1111/j.1600-065X.2010.00915.x. Immunol Rev. 2010. PMID: 20636821 Review.
-
Molecules in focus: indoleamine 2,3-dioxygenase.Int J Biochem Cell Biol. 2007;39(12):2167-72. doi: 10.1016/j.biocel.2007.01.004. Epub 2007 Jan 20. Int J Biochem Cell Biol. 2007. PMID: 17320464 Review.
-
Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses.J Neuroinflammation. 2016 Apr 18;13(1):79. doi: 10.1186/s12974-016-0551-5. J Neuroinflammation. 2016. PMID: 27090635 Free PMC article.
-
Tumor immune escape mediated by indoleamine 2,3-dioxygenase.Immunol Lett. 2007 Aug 15;111(2):69-75. doi: 10.1016/j.imlet.2007.06.001. Epub 2007 Jul 2. Immunol Lett. 2007. PMID: 17644189 Review.
Cited by
-
Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting.Transl Oncol. 2024 Nov;49:102096. doi: 10.1016/j.tranon.2024.102096. Epub 2024 Aug 22. Transl Oncol. 2024. PMID: 39178574 Free PMC article. Review.
-
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.Cancer Rep (Hoboken). 2024 Aug;7(8):e2146. doi: 10.1002/cnr2.2146. Cancer Rep (Hoboken). 2024. PMID: 39158178 Free PMC article. Review.
-
The role of tryptophan metabolism and tolerogenic dendritic cells in maintaining immune tolerance: Insights into celiac disease pathogenesis.Immun Inflamm Dis. 2024 Aug;12(8):e1354. doi: 10.1002/iid3.1354. Immun Inflamm Dis. 2024. PMID: 39150219 Free PMC article. Review.
-
Gingival mesenchymal stem cells: Biological properties and therapeutic applications.J Oral Biol Craniofac Res. 2024 Sep-Oct;14(5):547-569. doi: 10.1016/j.jobcr.2024.07.003. Epub 2024 Jul 13. J Oral Biol Craniofac Res. 2024. PMID: 39108352 Free PMC article.
-
Characterising the urinary acylcarnitine and amino acid profiles of HIV/TB co-infection, using LC-MS metabolomics.Metabolomics. 2024 Aug 3;20(5):92. doi: 10.1007/s11306-024-02161-8. Metabolomics. 2024. PMID: 39096437 Free PMC article.
References
-
- Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity. 2007;27:173–178. - PubMed
-
- Pallotta MT, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12:870–878. - PubMed
-
- Orabona C, et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood. 2006;107(7):2846–2854. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous